scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1085880336 |
P356 | DOI | 10.1038/BJC.2017.164 |
P932 | PMC publication ID | 5520514 |
P698 | PubMed publication ID | 28588321 |
P2093 | author name string | Rong Ma | |
Ye Wang | |||
Hui-Fang Liang | |||
Nian-Feng Sun | |||
An-Hong Zhang | |||
Fu-Yao Liu | |||
Shao-Jun Zhou | |||
Yuan-Hui Jiang | |||
P2860 | cites work | Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer | Q44963804 |
PI3 kinase/Akt signaling mediates epithelial-mesenchymal transition in hypoxic hepatocellular carcinoma cells | Q46079689 | ||
Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment | Q46593339 | ||
N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma | Q47290074 | ||
N-cadherin as a novel prognostic marker of progression in superficial urothelial tumors. | Q51210705 | ||
Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients. | Q51746993 | ||
High-throughput tissue microarray analysis used to evaluate biology and prognostic significance of the E-cadherin pathway in non-small-cell lung cancer. | Q54545606 | ||
Diagnosis and Treatment of Hepatocellular Carcinoma | Q56172242 | ||
N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells | Q73812967 | ||
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancer | Q74256215 | ||
N-cadherin expression in breast cancer: correlation with an aggressive histologic variant--invasive micropapillary carcinoma | Q81420248 | ||
Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients | Q81458955 | ||
Hallmarks of Cancer: The Next Generation | Q22252312 | ||
Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
MicroRNA signatures in human cancers | Q27860962 | ||
miR-15a and miR-16-1 in cancer: discovery, function and future perspectives | Q28247489 | ||
Causes and consequences of microRNA dysregulation in cancer | Q28258994 | ||
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis | Q28306363 | ||
MicroRNA biogenesis: coordinated cropping and dicing | Q29547496 | ||
MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer | Q29616316 | ||
Non-Smad pathways in TGF-beta signaling | Q29620040 | ||
miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia | Q33924575 | ||
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes | Q34186822 | ||
T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression | Q34811769 | ||
MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway | Q35274515 | ||
Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis | Q36316373 | ||
MiR-181b regulates cisplatin chemosensitivity and metastasis by targeting TGFβR1/Smad signaling pathway in NSCLC. | Q36333514 | ||
MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma | Q37225640 | ||
Cadherins and cancer: how does cadherin dysfunction promote tumor progression? | Q37333596 | ||
MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal transition in gastric cancer through up-regulating PTEN expression | Q37687107 | ||
A regulatory loop involving miR-29c and Sp1 elevates the TGF-β1 mediated epithelial-to-mesenchymal transition in lung cancer | Q37699150 | ||
Three functions of cadherins in cell adhesion | Q38124067 | ||
EMT: 2016. | Q38883448 | ||
Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers | Q39078029 | ||
MiR-199b-5p targets HER2 in breast cancer cells | Q39214783 | ||
Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma | Q39503251 | ||
HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-β signaling and is transcriptionally regulated by Slug | Q39550377 | ||
MicroRNA-125b attenuates epithelial-mesenchymal transitions and targets stem-like liver cancer cells through small mothers against decapentaplegic 2 and 4. | Q40962436 | ||
Akt promotes endocardial-mesenchyme transition | Q41874128 | ||
Phosphatidylinositol 3-kinase function is required for transforming growth factor beta-mediated epithelial to mesenchymal transition and cell migration. | Q42492769 | ||
A switch from E-cadherin to N-cadherin expression indicates epithelial to mesenchymal transition and is of strong and independent importance for the progress of prostate cancer | Q42522113 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International | Q42553662 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | microRNA | Q310899 |
P304 | page(s) | 233-244 | |
P577 | publication date | 2017-06-06 | |
P1433 | published in | British Journal of Cancer | Q326309 |
P1476 | title | MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma | |
P478 | volume | 117 |
Q88091795 | Comment on 'MicroRNA-199b-5p attenuates TGF-β1-induced epithelial-mesenchymal transition in hepatocellular carcinoma' |
Q47220613 | Curcumin downregulates the expression of Snail via suppressing Smad2 pathway to inhibit TGF-β1-induced epithelial-mesenchymal transitions in hepatoma cells |
Q55625598 | Isoviolanthin Extracted from Dendrobium officinale Reverses TGF-β1-Mediated Epithelial⁻Mesenchymal Transition in Hepatocellular Carcinoma Cells via Deactivating the TGF-β/Smad and PI3K/Akt/mTOR Signaling Pathways. |
Q50099317 | KSHV oral shedding and plasma viremia result in significant changes in the extracellular tumorigenic miRNA expression profile in individuals infected with the malaria parasite |
Q92838199 | Long non-coding RNA lncTCF7 predicts poor prognosis and promotes tumor metastasis in osteosarcoma |
Q90746297 | MiR-34a-5p Inhibits Proliferation, Migration, Invasion and Epithelial-mesenchymal Transition in Esophageal Squamous Cell Carcinoma by Targeting LEF1 and Inactivation of the Hippo-YAP1/TAZ Signaling Pathway |
Q61445008 | MicroRNA-197-3p acts as a prognostic marker and inhibits cell invasion in hepatocellular carcinoma |
Q57052686 | N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer |
Q64113780 | Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression |
Q55506760 | Role of microRNAs in the main molecular pathways of hepatocellular carcinoma. |
Q60961386 | The Epigenetic Regulation of HCC Metastasis |
Q57493789 | The Role of MicroRNAs in Hepatocellular Carcinoma |
Q55456736 | The Tumorgenicity of Glioblastoma Cell Line U87MG Decreased During Serial In Vitro Passage. |
Q64085684 | Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells |
Q92366579 | eIF4E‑related miR‑320a and miR‑340‑5p inhibit endometrial carcinoma cell metastatic capability by preventing TGF‑β1‑induced epithelial‑mesenchymal transition |
Q64279855 | miR-130a-3p regulated TGF-β1-induced epithelial-mesenchymal transition depends on SMAD4 in EC-1 cells |
Q102388831 | miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition |
Search more.